logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11085080 B1

PDFFull Text
Date of Patent:
Aug. 10, 2021

Filed:

Jul. 25, 2016

Use of il-3, il-33 and il-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus

Applicant:

Pontificia Universidad Catolica DE Chile, Santiago, CL;

Inventors:

Alexis Mikes Kalergis Parra, Santiago, CL;

Susan Marcela Bueno Ramirez, Santiago, CL;

Jose Pablo Bertrand Navarrete, Santiago, CL;

Margarita Kam-Lem Lay Remolcoi, Santiago, CL;

Assignee:

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE, Santiago, CL;

Attorney:

Lucas & Mercanti, LLP

Primary Examiner:

Dong Jiang

Int. Cl.
CPC ...
G01N 33/53 (2006.01); C12Q 1/6883 (2018.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); G01N 33/6893 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/005 (2013.01); G01N 2333/54 (2013.01); G01N 2333/5403 (2013.01); G01N 2333/5434 (2013.01); G01N 2800/12 (2013.01); G01N 2800/54 (2013.01);
Abstract

The present invention is related to detecting respiratory diseases using molecular markers as prognostic tool of the evolution of respiratory infection cases. Concretely, during the differential diagnostic of respiratory infections caused by the Syncytial Respiratory Virus and human Metapneumovirus, it will be established the expression pattern of the severity markers of IL-3, IL-33 and IL12p40. The expression pattern of the molecular markers can be defined in biological samplers using ELISA assays, flow cytometry or PCR in real time. The confirmation of the etiological agent of the infection in combination to the pattern definition of the molecular markers IL-3, IL-33 and IL12p40 will indicate a prognostic of the disease severity.

Find Patent Forward Citations

Kalergis Parra, Alexis. (2021). Use of il-3, il-33 and il-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus (U.S. Patent No. 11085080). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11085080

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…